INTRODUCTION
COVID-19 showed that rapid vaccine development and roll-out, while lifesaving, can still yield large, avoidable harms when equity is not considered from the outset. Disparities in vaccine timing and coverage, especially in low-resource settings, amplified health and economic burdens, highlighting the need...
M. Ghafari, O. J. Watson, Stefan Dascalu et al.· Expert Review of Vaccines· 0 citations
The status of immunisation services in Kano and Lagos States of Nigeria is assessed to inform the design of interventions to address high numbers of zero-dose and under-immunised children in these states.
A. Salaudeen, O. Bolarinwa, C. McGowan et al.· Health Services Insights· 0 citations
HPV vaccination holds considerable promise in reducing the burden of non-cervical cancers among women in LMICs, especially in regions with high incidence and limited access to care.
A. Tuli, M. Jit, K. Abbas et al.· BMJ Global Health· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.